Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award | MD | Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished radiologist and internationally respected leader in breast imaging, currently serving as Professor and Vice Chair for Breast Imaging in the Department of Diagnostic, Molecular, and Interventional Radiology at the Icahn School of Medicine at Mount Sinai, where she has made transformative contributions to breast cancer detection, digital imaging, and womenโ€™s health. Dr. Laurie Margolies completed her undergraduate studies in Biomedical Ethics at Brown University, earned her medical degree from Yale University School of Medicine, and pursued advanced clinical training through an internal medicine internship at Griffin Hospital, a radiology residency at Columbia-Presbyterian Medical Center, and a comprehensive fellowship in CT, ultrasound, and MRI at Yale University/Yale New Haven Hospital. Her professional experience spans decades of academic appointments, including Instructor at Yale, rising through faculty ranks at Mount Sinai from Assistant Professor to full Professor, while simultaneously serving as System Chief of Breast Imaging across multiple hospitals, Director of Breast Imaging at Mount Sinai Hospital, and Chief of Breast Imaging at the Dubin Breast Center. Dr. Laurie Margoliesโ€™s research interests center on breast cancer screening optimization, digital mammography, cardiovascular risk evaluation through mammographic arterial calcifications, health disparity reduction, culturally targeted education programs, imaging physics, AI-driven diagnostic tools, and cross-disciplinary cancer detection methods. Her research skills include expertise in multimodality breast imaging, tomosynthesis assessment, radiologic quality control, population-based screening program development, clinical guideline evaluation, and participation in collaborative research teams across oncology, epidemiology, psychology, and medical physics. She has contributed to impactful studies published in reputable journals such as the Journal of Breast Imaging, Clinical Imaging, Journal of Cancer Education, and PEC Innovation, and she has served on multiple advisory boards for leading medical technology companies, advancing AI-assisted imaging development. Dr. Laurie Margolies has received numerous honors, including Fellowship in the American College of Radiology, Fellowship in the Society of Breast Imaging, multiple RSNA Merit Awards, Mount Sinai Innovation Awards, Clinical Imaging Outstanding Reviewer recognition, and repeated selection as a Castle Connolly Top Doctor. She has served on key institutional committees, leadership panels, and mentoring programs, significantly shaping radiologic quality improvement and cancer screening strategies. Dr. Laurie Margolies continues to influence clinical practice through her dedication to research, patient-centered care, and educational advancement, embodying excellence in academic radiology and demonstrating ongoing potential to elevate global breast imaging standards.

Profile: ORCID | Google Scholar

Featured Publicationsย 

  1. Margolies, L. R., Spear, G. G., Payne, J. I., Iles, S. E., & Abdolell, M. (2025). Artificial intelligence for assessment of digital mammography positioning reveals persistent challenges.

  2. Rossi, J., Cho, L., Newell, M. S., Venta, L. A., Montgomery, G. H., Destounis, S. V., Brem, R. F., Parghi, C., & Margolies, L. R. (2025). Breast arterial calcifications on mammography: A review of the literature.

  3. Mullen, L. A., Ambinder, E. B., Talati, N., & Margolies, L. R. (2023). Mammography information systems: A survey of breast imaging radiologist satisfaction and perspectives.

  4. Head, K. J., Harrington, N. G., Schnur, J. B., Margolies, L., & Montgomery, G. H. (2022). Examining gain- and loss-framed messages in a novel breast cancer screening/cardiovascular context: Does framing matter.

  5. Vang, S., Margolies, L. R., & Jandorf, L. (2022). Screening mammogram adherence in medically underserved women: Does language preference matter.

  6. Fung, J., Vang, S., Margolies, L. R., Li, A., Blondeau-Lecomte, E., Li, A., & Jandorf, L. (2021). Developing a culturally and linguistically targeted breast cancer educational program for a multicultural population.

  7. Margolies, L. R., Salvatore, M., Yip, R., Tam, K., Bertolini, A., Henschke, C., & Yankelevitz, D. (2018). The chest radiologistโ€™s role in invasive breast cancer detection.

 

Tianhui Yuan | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Dr. Tianhui Yuan | Medicine and Health Sciences | Best Researcher Award

Associate Director | The First Affiliated Hospital of Guangzhou University of Medicine | China

Prof. Dr. Tianhui Yuan is a distinguished physician-scientist whose educational journey culminated in the M.D. and a Ph.D. in integrated medicine and cardiovascular science (with doctoral training at a leading university), and she currently serves as Chief Physician, Doctoral Supervisor, and Associate Director of her department while also holding a Visiting Scholar appointment in the United States. Over her career, she has held progressive roles in clinical practice, laboratory research, and academic leadership in integrative Chinese and Western medicine. Her professional experience spans directing clinical care units in cardiovascular medicine, mentoring doctoral and postdoctoral researchers, coordinating international research collaborations, and representing her institution in health policy and traditional medicine networks. Her research interests lie at the interface between traditional Chinese medicine and modern cardiovascular disease therapy, particularly focusing on mechanisms and therapeutic strategies for heart failure, cardiomyopathy, coronary artery disease, hypertension, arrhythmia, hyperlipidemia, and insomnia. She is skilled in experimental cardiovascular physiology, molecular biology, signaling pathway analysis, preclinical animal models, translational interventions, and clinical guideline development. She has made significant scholarly contributions: she has authored 15 documents, received 154 Citations, and holds an h-index of 7, reflecting a growing impact. Among her honors and awards, she has been selected for the Guangdong Provincial Health Commissionโ€™s โ€œGuangdong Special Support Programโ€ and the โ€œYouth Talent Support Program,โ€ and she holds recognition as a young academic leader at her university; she also serves on multiple national and international professional committees and has contributed to guideline development, patent filing (2 invention patents), software intellectual property (1 software copyright), and the authorship of 9 books. Through mentorship she has guided student teams to high distinction in innovation competitions and has been invited as a keynote speaker at major conferences like the ESC Heart Failure Congress and the International Heart Congress. Given her solid educational foundation, extensive clinical and research experience, integrative medicine focus, leadership roles, and peer-recognized contributions, Prof. Dr. Tianhui Yuan is exceptionally well positioned to advance her field further, strengthen international collaborations, expand high-impact publication outputs, and mentor the next generation of integrative cardiovascular researchers.

Profile: Scopus

Featured Publications

  1. Ma, X., โ€ฆ Yuan, T. (2023). Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula to prevent myocardial ischemia. Journal Name.

  2. Dong, X., Han, X., Zhang, X., โ€ฆ Yuan, T. (2022). A simplified herbal formula improves cardiac function and reduces inflammation in mice through the TLR-mediated NF-ฮบB signaling pathway. Journal Name.

  3. Yang, Z., Xian, S., Yuan, T. (2020). Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury. Journal Name.

  4. Yuan, T., Chen, Y., Zhou, X., โ€ฆ (2019). Effectiveness and safety of Danshen injection on heart failure: protocol for a systematic review and meta-analysis. Journal Name.

  5. Wang, L., Gao, M., Chen, J., โ€ฆ (2015). Resveratrol ameliorates pressure overload-induced cardiac dysfunction and attenuates autophagy in rats. Journal Name.

 

Muhammad Tahir Aleem | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Mr. Muhammad Tahir Aleem | Medicine and Health Sciences | Best Researcher Award

Researcher | Shantou University Medical College | China

Mr. Muhammad Tahir Aleem is an accomplished veterinary scientist and postdoctoral researcher recognized for his significant contributions to Preventive Veterinary Medicine, Molecular Parasitology, and Infectious Disease Research. He has developed a strong interdisciplinary foundation that bridges veterinary and biomedical sciences through his extensive global academic and research journey. Mr. Muhammad Tahir Aleem earned his Doctor of Veterinary Medicine (DVM) and M.Phil. in Parasitology from the University of Agriculture, Faisalabad, Pakistan, followed by a Ph.D. in Preventive Veterinary Medicine from Nanjing Agricultural University, China, where his research focused on molecular and immunological aspects of parasitic infections. He further enhanced his expertise through postdoctoral research in Molecular Parasitology and Chromosome Biology at Cleveland State University, USA, and Basic Medicine at Shantou University Medical College, China. His educational background reflects a continuous pursuit of scientific excellence and innovation in veterinary and biomedical disciplines. Professionally, Mr. Muhammad Tahir Aleem is affiliated with the MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, where he actively contributes to research and mentorship in the fields of parasitology, immunology, and infectious diseases. Throughout his academic journey, he has collaborated with international research teams from the United States, China, and Pakistan, focusing on drug development, molecular diagnostics, immunological responses, vaccine development, and zoonotic disease prevention. His research endeavors aim to bridge the gap between human and animal health through innovative molecular and immunological techniques. Mr. Muhammad Tahir Aleem has authored 71 documents, received 519 citations, and holds an h-index of 11, demonstrating his impactful contribution to global scientific literature. His publications in high-impact journals such as Vaccines, Frontiers in Immunology, International Immunopharmacology, and Biomedical Research International reflect his dedication to advancing molecular parasitology and preventive medicine.

Profile:ย ย Google scholarย |ย Scopus

Featured Publications

  1. Aleem, M. T., Jiawen, S., Qing Yu, Z., Wen, Z., Yang, Z., & Yan, R. (2021). Characterization of membrane-associated progesterone receptor component-2 (MAPRC2) from Trichinella spiralis and its interaction with progesterone and mifepristone. Vaccines, 9, 934. (Citations: 42)

  2. Aleem, M. T., Khan, A., Wen, Z., Yu, Z., Kun, L., & Cheng, C. (2022). Molecular docking and in silico simulation of Ts-MAPRC2 and its interaction with human-progesterone membrane component-1 (H-PGRMC1). Biomedical Research International. (Citations: 33)

  3. Aleem, M. T., Munir, F., Shakoor, A., & Gao, F. (2024). mRNA vaccines against infectious diseases and future direction. International Immunopharmacology, 135, 112320. (Citations: 27)

  4. Aleem, M. T., Mohsin, M., Shahid, Z., & Ijaz, A. (2023). A review on recent advancement in the molecular diagnostics of Leishmania. Journal of Hellenic Veterinary Medical Society, 74, 5551โ€“5568. (Citations: 12)

  5. Shaukat, A., Aleem, M. T., Munir, F., & Gao, F. (2025). An overview of the role of steroid hormones in various parasitic infections. Journal of Reproductive Immunology, 169, 104533. (Citations: 8)

 

Qianheng Jin | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Qianheng Jin | Medicine and Health Sciences | Best Researcher Award

Dr. Qianheng Jin | Medicine and Health Sciences | Attending physician | Suzhou Ruihua Orthopedic Hospital | China

Dr. Qianheng Jin is a highly accomplished physician and researcher whose work bridges clinical orthopedics and regenerative medicine. With a career rooted in advancing patient care, he has combined surgical expertise with pioneering biomedical research, focusing on innovative approaches in tissue engineering, wound healing, and bioprinting. His professional journey highlights a consistent commitment to improving treatment outcomes, particularly in complex reconstructive procedures and vascularized tissue regeneration. Dr. Qianheng Jin is recognized for integrating advanced research into clinical practice, making significant contributions to both academic science and applied medical solutions that directly benefit patients.

Professional Profileย 

Education

Dr. Qianheng Jin pursued his advanced medical and doctoral studies at Soochow University, where he specialized in the fields of orthopedic surgery, regenerative medicine, and biomedical engineering. His academic training emphasized translational research, with a focus on developing engineered tissues and vascularized constructs capable of improving clinical outcomes in reconstructive surgery. Through rigorous education and extensive research engagement, Dr. Qianheng Jin has cultivated deep expertise in surgical techniques, tissue biology, and biomaterial applications, which now form the foundation of his academic and clinical contributions.

Experience

Dr. Qianheng Jin serves as a physician at Suzhou Ruihua Orthopedic Hospital, where he applies his knowledge in treating complex injuries and performing advanced replantation surgeries. His professional experience is characterized by a balance between hands-on surgical practice and groundbreaking laboratory-based innovations. In his role, he has contributed to the establishment of emergency protocols for major limb replantation, leading to significant improvements in patient outcomes. Beyond clinical service, he has actively participated in collaborative research projects that link medical institutions and international academic communities. This blend of professional experience underscores his ability to merge theory and practice while fostering a collaborative research culture.

Research Interest

The research interests of Dr. Qianheng Jin lie in the intersection of regenerative medicine, bioprinting technologies, and clinical orthopedics. His work particularly focuses on the development of engineered dermal tissues, small-diameter vascular grafts, and advanced wound healing strategies. He has contributed to the exploration of bioprinted vascularized constructs that mimic natural tissue structures and improve graft survival. Additionally, his studies extend to investigating molecular mechanisms that influence tissue repair and regeneration, offering valuable insights into translational applications. Dr. Qianheng Jin work demonstrates his dedication to advancing clinical solutions through innovative biomedical technologies that address unmet challenges in reconstructive medicine.

Award

Dr. Qianheng Jin has been recognized for his contributions through academic excellence, impactful research, and clinical innovation. His published works in highly respected journals highlight his role as a thought leader in regenerative medicine and bioprinting. These achievements underscore his eligibility for awards that honor research excellence, clinical impact, and international collaboration. His record reflects not only scholarly productivity but also the translation of research into practical applications, affirming his status as a deserving candidate for this nomination.

Selected Publication

  • A multidisciplinary emergency protocol reduces revascularization time in major upper and lower limb replantations (2025) โ€“ 18 Citations

  • Bioprinted dermis with human adipose tissueโ€derived microvascular fragments promotes wound healing (2024) โ€“ 32 Citations

  • Engineered dermis loaded with confining forces promotes full-thickness wound healing by enhancing vascularisation and epithelialisation (2023) โ€“ 27 Citations

  • Bioprinting small diameter blood vessel constructs with an endothelial and smooth muscle cell bilayer in a single step (2020) โ€“ 41 Citations

Conclusion

Dr. Qianheng Jin exemplifies the qualities of an outstanding clinician-researcher whose dedication to advancing science and medicine has resulted in significant contributions to orthopedic surgery, regenerative medicine, and biomedical engineering. His career reflects a rare balance between direct patient care and innovative research, producing outcomes that resonate within both clinical practice and global academic discourse. With a growing body of high-impact publications, international collaborations, and leadership in clinical innovation, Dr. Qianheng Jin continues to pave the way for advancements in reconstructive medicine. His achievements, professional dedication, and potential for future breakthroughs make him an exceptional candidate for this award nomination, representing both scientific excellence and meaningful societal contribution.

 

Karen Allison | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Karen Allison | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Karen Allison, University of Rochester, United States

Assoc. Prof. Dr. Karen Allison is a dedicated ophthalmologist specializing in glaucoma care ๐Ÿ‘๏ธโ€๐Ÿ—จ๏ธ. She holds a Doctor of Medicine from Robert Wood Johnson Medical School (1990) ๐ŸŽ“ and an MBA from George Washington University (2013). Currently at the Flaum Eye Institute, she serves as Glaucoma Service Chief and Fellowship Director ๐Ÿ‘ฉโ€โš•๏ธ. With extensive experience in clinical research and education, Dr. Allison has authored impactful studies on glaucoma, disparities in healthcare, and genetic factors in ocular diseases ๐Ÿ“š๐Ÿงฌ. Her accolades include Leading Physicians in the World and the Women of Distinction honors ๐ŸŒŸ. Sheโ€™s a passionate advocate for diversity and health equity ๐Ÿ’™.

Publication Profile

Orcid

Education

Associate Professor Dr. Karen Allison holds a Doctor of Medicine (M.D.) degree from the University of Medicine and Dentistry of New Jersey (Robert Wood Johnson Medical School), earned in May 1990 ๐Ÿฉบ๐Ÿ“š. Further enhancing her expertise, she pursued a Master of Business Administration (M.B.A.) at The George Washington University in Washington, D.C., graduating in January 2013 ๐ŸŽ“๐Ÿ’ผ. With a strong foundation in both medicine and business, Dr. Allison combines her clinical acumen and strategic leadership to excel in academia and healthcare management ๐ŸŒŸ๐ŸŒ. Her interdisciplinary background empowers her to contribute meaningfully to education, research, and organizational development. ๐ŸŒฟ๐Ÿ“–

Certifications and Professional Experienceย 

Assoc. Prof. Dr. Karen Allison is a board-certified ophthalmologist with extensive expertise in both private practice and academia. ๐ŸŒŸ Her significant contributions at the Flaum Eye Institute include serving as Glaucoma Fellowship Director and Glaucoma Service Chief, showcasing her leadership and dedication to advancing ophthalmic care. ๐Ÿ‘๏ธโ€๐Ÿ—จ๏ธ With a deep commitment to education and innovation in glaucoma management, she bridges clinical excellence with academic rigor. ๐Ÿ“š๐Ÿ’ก Dr. Allison’s efforts reflect her unwavering passion for improving patient outcomes and mentoring future ophthalmologists, solidifying her reputation as a respected figure in the field of ophthalmology. ๐Ÿฅ๐ŸŒฟ

Editorial Roles and Recognitionย 

Assoc. Prof. Dr. Karen Allison is a leading figure in ophthalmic research and clinical practice ๐ŸŒŸ๐Ÿ‘๏ธโ€๐Ÿ—จ๏ธ. Her editorial roles in prestigious journals, including the Cureus Journal of Medical Science and the Journal of Medical Case Reports ๐Ÿ“š๐Ÿ–‹๏ธ, underscore her commitment to advancing the field. Through her peer-reviewed publications in high-impact journals ๐Ÿ“ฐ๐Ÿ“ˆ, Dr. Allison has made significant contributions to the academic community, fostering innovation and knowledge sharing. Her dedication to excellence in research and clinical care continues to inspire professionals and students alike, driving progress in ophthalmology and beyond ๐ŸŒ๐Ÿ”ฌ.

Awards and Honorsย 

Assoc. Prof. Dr. Karen Allison is a distinguished ophthalmologist honored with multiple accolades for her contributions to the field and community. She was featured in the Nationwide Registries Women of Distinction Honors Edition in 2021, and recognized as one of the Leading Physicians in the World in 2013. Dr. Allison was named a Top Ophthalmologist in New York in 2013 and 2014. Her dedication to community service earned her awards from the Lions Club of Brooklyn-Kings County in 2013 and the St. Kitts Organization in 2007. ๐ŸŒŸ๐Ÿ‘ฉโ€โš•๏ธ๐Ÿ…๐ŸŒ

Research Supervision and Mentorshipย 

Assoc. Prof. Dr. Karen Allison is dedicated to shaping the next generation of researchers. Her commitment shines through her creation of the glaucoma intern research fellowship, which provides invaluable hands-on experience. Beyond that, she has mentored high school students, medical students, and residents, fostering their growth through guidance and supervision of impactful research. This personalized, nurturing approach to education makes her an exceptional academic mentor, helping students thrive in both clinical and research settings. Her passion for teaching and research mentorship is truly inspiring. ๐Ÿง‘โ€๐Ÿซ๐Ÿ”ฌ๐Ÿ‘ฉโ€๐Ÿ”ฌ๐Ÿ’ก๐Ÿ“š

Research Focus

Assoc. Prof. Dr. Karen Allisonโ€™s research primarily focuses on ocular health disparities, particularly glaucoma and age-related macular degeneration (AMD). Her work examines racial, ethnic, and gender disparities in eye care access and treatment, analyzing patterns in gene expression and clinical outcomes across different populations. She evaluates the impact of socioeconomic factors on the utilization of eye care services, leveraging data from sources like the CDCโ€™s Behavioral Risk Factor Surveillance System. Her studies also delve into the genetic underpinnings of eye diseases, seeking to better understand variations in macular tissues and their role in AMD progression. ๐Ÿ‘๏ธ๐Ÿ“Š๐Ÿงฌ๐Ÿ‘ฉโ€๐Ÿ”ฌ

Publication Top Notes

Risk factors affecting the utilization of eye care services evaluated by the CDC’s behavior risk factor surveillance system from 2018 to 2021

Uveal effusion syndrome: a case report

Racial and Gender Disparities for Glaucoma Treatment Rates in Upstate New York

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration

Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials A Systematic Review and Meta-analysis